WWM
COCP icon

Western Wealth Management’s Cocrystal Pharma COCP Stock Holding History

Western Wealth Management’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,901
Closed -$10K – 815
2022
Q2 		$10K Hold
1,901
– – ﹤0.01% 782
2022
Q1 		$13K Buy
+1,901
New +$12.6K ﹤0.01% 820
2021
Q2 		$24K Buy
+1,593
New +$24.2K ﹤0.01% 619

Other funds holding COCP

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Western Wealth Management's COCP Position: Q3 2022 in Review

Western Wealth Management sold out of Cocrystal Pharma (COCP) in Q3 2022, closing a stake of 1,901 shares — an estimated $10K sold.

Western Wealth Management first reported a position in COCP in Q2 2021 and held it in 3 quarters. The position peaked at $24K in Q2 2021. 27 funds tracked by Wall St. Rank hold COCP as of Q3 2022.

  • Western Wealth Management reported no remaining Cocrystal Pharma position as of Q3 2022 after selling out during the quarter.
  • Western Wealth Management sold 1,901 Cocrystal Pharma shares in Q3 2022, an estimated $10K.
  • Western Wealth Management first reported a position in Cocrystal Pharma in Q2 2021 and held it in 3 quarters.
  • Western Wealth Management's Cocrystal Pharma position peaked at $24K in Q2 2021.
  • 27 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q3 2022.

Based on Western Wealth Management's 13F filing for Q3 2022, filed 7 Nov 2022.